Gideon James Grogan

Professor Gideon James Grogan is a distinguished academic at the University of York, holding a position in the Department of Chemistry within the Faculty of Sciences. With expertise spanning structural and applied enzymology, he leads research at the intersection of chemistry and biology, developing novel biocatalysts for sustainable chemical synthesis and pharmaceutical applications.

Professor Grogan's research focuses on the identification, characterization, and application of enzymes with biotechnological potential. His work encompasses:

• Oxygenases including P450s, flavoprotein monooxygenases, and peroxygenases
• Reductases such as ketoreductases (KREDs), imine reductases (IREDs), and reductive aminases (RedAms)
• Lyases catalyzing asymmetric hydration of alkenes
• Ligases for amide bond formation

His multidisciplinary approach integrates synthetic chemistry, microbiology, molecular biology, and X-ray crystallography to engineer enzymes using in vitro evolution techniques. Recent research has yielded significant advances in biocatalytic pathways for chiral pharmaceutical precursors and renewable material processing.

Professor Grogan's publication record demonstrates consistent innovation in biocatalysis, with recent work focusing on peroxygenase applications, reductive amination technologies, and enzyme engineering for improved catalytic properties. His research shows strong trends in developing sustainable enzymatic routes for pharmaceutical synthesis, with particular emphasis on stereoselective transformations and cascade reactions.

Professor Grogan has received significant research funding through major grants from:

• BBSRC (Biotechnology and Biological Sciences Research Council)
• EPSRC (Engineering and Physical Sciences Research Council)

He actively supervises PhD students and collaborates extensively both within the University of York and internationally. His work bridges the Departments of Chemistry and the York Structural Biology Laboratory (YSBL), leveraging state-of-the-art facilities for organic synthesis, protein expression, and structural analysis.

Professor Grogan maintains strong industry connections, translating fundamental research into practical applications for pharmaceutical and chemical manufacturing. His current projects include sustainable production of menthol enantiomers, development of native amine dehydrogenases for chiral amine synthesis, and discovery of securinine alkaloid biosynthesis pathways.